Increasing HIV/STI Home Testing Via a Digital Intervention Among Black Women
Part of paid clinical trials in Austin, Texas.
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Study ID
- NCT05390541
- Status
- Terminated
Conditions
- Economic Problems
- Hiv
- Sexually Transmitted Diseases
Eligibility Criteria
- Sex
- FEMALE
- Age
- 15 Years - 59 Years
- Healthy Volunteers
- Accepted
Interventions
- Empowered to Test Yourself — BEHAVIORALThere will be 5 sessions of the intervention, all of which will follow the same format. Participants will be sent push notifications for each session. Each session will begin with using relevant constructs from sIMB (i.e., information and behavioral skills). Next, participants will choose positive outcomes resulting from the behavior, barriers to performing the behavior (mental contrasting), select situational cues and action plans to overcome selected barriers (implementation intentions), and practice typing in implementation intentions and positive outcomes from memory (memory practice). To ensure participants retain the implementation intentions, the investigators will use memory practice. Participants will be asked to self-code if the participant is correct or incorrect. Lastly, participants will learn behavioral skills to engage in each of the 5 actions to increase self-efficacy.
- Educational Control — OTHERParticipants will receive the HIV/STI home testing kit, instructions to mail in the kit, notification when results are ready to check online, treatment from a provider at Kind Clinic for positive results, and referral to Kind Clinic for PrEP. Each session and assessment will occur every 3 days. Session 1: Basic information about STIs. Session 2: HIV and stigma, basic information about HIV, and HIV transmission facts and myths. Session 3: Four stories about different people who are HIV-positive, how HIV was contracted, and one story about a woman who contracted herpes and how to all cope and live healthy lives. Session 4: How to disclose positive STI status. Session 5: Basic information about PrEP, and information on how to correctly use a male condom, female condom, and dental dam.
Study Details
The proposed intervention is a web-based intervention guided by theoretical components to increase HIV home testing among Black women at risk for HIV and sexually transmitted infections (STIs) in a HIV hotspot in the South. The intervention will promote using the home test, linkage to care, and linkage to pre-exposure prophylaxis (PrEP) evaluation. The intervention has the potential to be implemented on a large scale and tailored based on location and population to increase testing, treatment, and PrEP adoption.
Key Dates
- Start date
- Feb 2, 2022
- Status verified
- Apr 2026
- Primary completion
- Jun 30, 2025
- Completion
- Jun 30, 2025
Study Design
- Enrollment
- 31 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Active Comparator: Educational ControlParticipants will receive a generic standard of care via a combination of videos, audio, and text/graphics across 5 sessions during 4 weeks.
- Experimental: Empowered to Test YourselfThere will be 5 tailored web based sessions of the intervention over 4 weeks, all of which will follow the same format.
Primary Outcome Measure
Number of Participants Who Used Home HIV Test [ Time Frame: 4 days ]
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Johns Hopkins Bloomberg School of Public Health | Austin | Texas | 78701 | - |
| Johns Hopkins Bloomberg School of Public Health | Dallas | Texas | 75202 | - |
| Johns Hopkins Bloomberg School of Public Health | Houston | Texas | 77019 | - |
| Johns Hopkins Bloomberg School of Public Health | San Antonio | Texas | 78205 | - |
Find similar trials in Austin, TX
By condition
By specialty
Related Studies
- Real-world Effectiveness of HPV Vaccine in Women Living With HIV and Its Impact on Cervical Cancer Screening AccuraciesEnrolling By Invitation · University of California, Los Angeles · Denver, Colorado
- Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIVPHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Birmingham, Alabama
- Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-careNot Yet Recruiting · M.D. Anderson Cancer Center · Houston, Texas
- HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation StrategyRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas